Klivira
Request demo

Streamlining Aetna Beovu Prior Authorization Workflows

Klivira optimizes the complex process of Aetna Beovu prior authorization, ensuring your team can efficiently manage approvals for this critical ophthalmic therapy.

For revenue cycle leaders and prior authorization coordinators, navigating the specific requirements for high-volume specialty drugs like Beovu (brolucizumab) is crucial for patient access and reimbursement. Understanding Aetna's distinct submission channels, clinical criteria, and appeal pathways is key to minimizing delays and denials.

Aetna's Prior Authorization Channels for Beovu

Beovu (brolucizumab), as a specialty injectable for conditions like wet Age-related Macular Degeneration (AMD), typically falls under the medical benefit. Aetna routes the majority of medical-benefit precertification requests through the Availity provider portal, which serves as their primary multi-payer workspace. For high-volume submitters, direct X12 278 transactions via clearinghouses are also supported for applicable procedure categories.

Understanding Aetna's Clinical Policy for Beovu

Aetna's medical necessity criteria for specialty drugs, including Beovu, are published as Clinical Policy Bulletins (CPBs) within their public CPB library. These CPBs are versioned, dated, and provide the canonical identifier for specific utilization management requirements. They often detail indications, dosing, and any step-therapy protocols, making it essential for clinics to reference the current CPB number and review date for compliance.

Key Considerations for Aetna Beovu PA Submissions

  • Verify the specific Aetna Clinical Policy Bulletin (CPB) for brolucizumab, noting its effective date and version.
  • Confirm if Beovu is managed under the medical benefit (Availity/X12 278 submission) or a specialty-pharmacy-management workflow.
  • Ensure all required clinical documentation, including diagnosis, previous therapies, and patient-specific criteria, aligns with the applicable CPB.
  • Be prepared for potential step-therapy requirements, which are typically embedded within the drug's CPB rather than a separate registry.
  • Utilize electronic submission methods like the Availity portal or X12 278 to streamline processing and improve traceability.

Turnaround Times and Regulatory Impact on Beovu PA

Aetna's prior authorization turnaround times are influenced by state-specific regulations for commercial plans and federal mandates for Medicare Advantage (MA) and Medicaid managed care (Aetna Better Health). For MA and Medicaid lines, Aetna is an impacted payer under CMS-0057-F, requiring 72-hour decisions for standard PA requests and 24-hour for expedited, with phased compliance through 2027. NCQA Utilization Management accreditation also sets decision timeframe norms for accredited plans.

Navigating Denials and Appeals for Beovu

Common denial reasons for specialty injectables like Beovu often include insufficient documentation, lack of medical necessity, or failure to meet step-therapy requirements as outlined in the CPB. Aetna returns denial reasons via X12 835/277 transactions or portal updates, using standard CARC and RARC codes. The appeal pathway typically involves reconsideration, peer-to-peer review, and formal appeal, with specific timely-filing windows varying by line of business and state regulations.

Enhancing Efficiency with Klivira for Aetna Beovu PA

Klivira integrates directly with EMRs and payer portals, automating the submission and tracking of Aetna Beovu prior authorizations. Our platform leverages Aetna's specified channels, including Availity and X12 278, to accelerate the process, reduce manual effort, and improve first-pass approval rates by ensuring documentation aligns with current CPB requirements. This allows your team to focus on patient care rather than administrative burden.

Frequently asked questions

Which Aetna submission channels are typically used for Beovu prior authorizations?

For Beovu, generally covered under the medical benefit as a specialty injectable, primary submission channels include the Availity provider portal or direct X12 278 transactions through clearinghouses. Pharmacy-benefit electronic PA partners like CoverMyMeds or Surescripts are typically for retail pharmacy claims, not medical-benefit injectables.

How can I find Aetna's medical necessity criteria for Beovu?

Aetna publishes its medical necessity criteria for Beovu and other specialty drugs in its public Clinical Policy Bulletins (CPBs). You should consult the Aetna CPB library to find the most current CPB specific to brolucizumab, ensuring you reference the latest version and effective date for accurate submission.

Does Aetna have specific step-therapy requirements for Beovu?

Aetna incorporates any applicable step-therapy protocols directly within the relevant Clinical Policy Bulletins (CPBs) for specific drugs. To determine if Beovu has step-therapy requirements, you must review the current Aetna CPB for brolucizumab, as these details are embedded within the policy document.

What are common reasons for Aetna to deny a Beovu prior authorization?

Common denial reasons for specialty injectables like Beovu include insufficient clinical documentation to support medical necessity, failure to meet specific criteria outlined in the Clinical Policy Bulletin, or not adhering to required step-therapy protocols. Site-of-service mismatches or off-label use without compendium support can also lead to denials.

How does Klivira help with Aetna Beovu prior authorizations?

Klivira automates the prior authorization workflow for Aetna Beovu by integrating with your EMR and Aetna's submission portals like Availity. This ensures that requests are submitted through the correct channels with complete, accurate documentation aligned with Aetna's CPBs, reducing manual errors and accelerating decision times for this high-volume drug.

Related coverage

Other beovu prior authorization by payer

Other beovu prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo